# K132416: Rehastim 2, Erigopro (Fes)

- Pathway: 510(k) (Traditional)
- Applicant: Hasomed GmbH
- Decided: May 28, 2014 after 299 days
- Product code: GZI (Stimulator, Neuromuscular, External Functional)
- Device class: 2
- Regulation: 21 CFR 882.5810
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 4 generations back to K841112 (1984). 4 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 6 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K112844: Rehastim 2, Rehamove 2, Hasomed GmbH (2011). Our reading of the summary gave K112344, which is not a number in FDA’s lists. Corrected to the number one digit away whose FDA name carries the summary’s words for the device, “RehaStim 2; RehaMove 2”.

## Most influential descendants
- K162683: RehaStim 2 (2017), 0 descendants of its own

## Indications for use
The ErigoPro is intended for medical purposes such as to increase tolerance to an upright or standing position in patients with circulatory, neurological, or musculoskeletal conditions. ErigoPro is also used for: 1. Relaxation of muscle spasms 2. Prevention or retardation of disuse atrophy / redevelop muscles 3. Increasing local blood circulation 4. Maintaining or increasing joint range of motion

Source page: https://510kreport.com/device/K132416
Methodology: https://510kreport.com/methodology